Trials / Completed
CompletedNCT02766751
Treating Comorbid Pain and Depression in HIV+ Individuals
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 187 (actual)
- Sponsor
- Butler Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to look at two different programs that may help people who are HIV+ and have pain and depression. The investigators are trying to understand how to help people learn to live better lives even with these chronic illnesses.
Detailed description
The primary aim of this RCT is to evaluate the HIVPass intervention. HIV+ participants (n=236) with chronic pain and depression will be recruited at primary care HIV Clinics through posted advertisements in the waiting rooms of the PCP offices and by physician referral. After an initial phone study screen, research staff will meet with interested individuals in their PCP offices for informed consent, baseline interview and randomization into one of two study groups (Health Education or HIVPass Counseling). Seven intervention sessions (HE or HIVPASS) will occur during the first 3 months of study participation. For all participants, the first session is a collaborative in-person joint session with the participant, his/her PCP and the study BHS. Session 2 is conducted immediately after this collaborative session, and is also in-person. Sessions 3-7 are conducted by phone. Follow-up assessment interviews will be at months 1, 2, 3 (post-intervention), 4, 6, 9 and 12.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | HIVPASS | The 7-session HIVPASS intervention is provided to individuals randomized to the HIVPASS study arm. |
| BEHAVIORAL | Health Education | The 7-sessions of Health Education is provided to individuals randomized to the Health Education study arm. |
Timeline
- Start date
- 2016-11-15
- Primary completion
- 2020-07-01
- Completion
- 2021-05-01
- First posted
- 2016-05-10
- Last updated
- 2021-06-10
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02766751. Inclusion in this directory is not an endorsement.